联系人：李经理
手机：18116171568
邮箱：lgj@theramabs.com
地址：上海浦东新区惠南镇东征路133号
网址：www.Theraprotein.com
Product Name：Bevacizumab |
Introduction: |
This product is the biosimilar of Bevacizumab (216974-75-3), which is vascular endothelial growth factor directed antibody. It is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions, which is produced in a mammalian cell (Chinese Hamster Ovary) expression system, and has an approximate molecular weight of 149 kDa. *Statement: this product is used for R&D and IND only, not for clinical and commercial usage before registered in drug registration authority. |
Features and Advantages: |
| NameBevacizumabCAS NO.216974-75-3TypeWhole antibodySourceHumanized (from mouse)TargetVEGF-ACloneMonocloneFormulaC6638H10160N1720O2108S44Molecular Weight149 kDaAntibody FormPurified immunoglobulinPhysical FormSolution in phosphate buffered salinePlace of OriginUSAStorageSealed and stored at -70±15℃, away from light |
Specifications: |
The Bevacizumab is supplied at 2mg/tube, 5mg/tube, 10mg/tube, 20mg/tube as a sterile, clear and colorless, preservative-free solution. |
Quality Assurance： |
(1) We have advanced technology and equipment to satisfy the requirements of GMP. All the raw material purchasing and production quality control are strictly following the ISO9001. (2) We own a group of QCs with rich experience, mainly engaging in testing APIs, intermediates and finished products. Before posting, all of the stuffs must receive professional training and GMP courses. (3) The COA(Certificate of Analysis), MOA(Method of Analysis), SDS(Stability Data Sheet), DMF(Drug Master File) and MSDS(Material Safety Data Sheet) are available. |